IO Biotech, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
IOBT on Nasdaq
Industry
Pharmaceutical Preparations
Location
Ole Maaloes Veh 3, Copenhagen, Denmark

Insiders trading volume in the past year

IO Biotech, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Invest A/S Lundbeckfond Director, 10%+ Owner $14.4 M Aug 9, 2023
Christian Elling Director $14.4 M Jun 6, 2024
Holdings A/S Novo 10%+ Owner $10.4 M +$8.21 M +375% May 10, 2024
Vivo Capital IX, LLC 10%+ Owner $9.51 M +$6 M +171% Aug 9, 2023
HBM Healthcare Investments (Cayman) Ltd. 10%+ Owner $2.78 M Nov 9, 2021
Claus Andersson Director $1.85 M Nov 9, 2021
Kurma Partners 10%+ Owner $645 K Aug 9, 2023
Vanessa Malier Director $446 K Nov 9, 2021
Amy Sullivan Chief Financial Officer $77 K Mar 15, 2024
Mai-Britt Zocca Chief Executive Officer, Director $66.2 K Mar 15, 2024
Brian Burkavage Chief Accounting Officer $11.9 K +$10.1 K +569% Mar 15, 2024
Devin W. Smith General Counsel $5.11 K Mar 15, 2024
Emmanuelle Coutanceau Director Nov 4, 2021
Keith Vendola Chief Financial Officer Nov 4, 2021
Eva Ehrnrooth Chief Medical Officer Mar 20, 2023
Muhammad Al-Hajj Chief Scientific Officer Mar 20, 2023
Qasim Ahmad Chief Medical Officer Mar 15, 2024
Jack Nielsen Director Jun 8, 2023
Heidi Hunter Director Jun 6, 2024
Helen Louise Collins Director Jun 6, 2024
David V. Smith Director Jun 6, 2024
Kathleen Sereda Glaub Director Jun 6, 2024
Priyanka Belawat Director Nov 4, 2021
Peter Hirth Director Jun 6, 2024

Recent Insider Transactions by Companies or Individuals for IO Biotech, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership